SCHEMBL12201496

SCHEMBL12201496

c1ccc(C(=NNc2cc3c4ccccc4c(NN=C(c4ccccc4)c4ccccc4)cc3c3ccccc23)c2ccccc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
GAA P10253 3/20 0.44
MAPT P10636 2/20 0.42
MAPK1 P28482 1/20 0.40
RECQL P46063 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
CTSL P07711 5/20 0.39
RAB9A P51151 1/20 0.39
CTSK P43235 1/20 0.36
HNF4A P41235 1/20 0.36
CTSB P07858 1/20 0.36
HPGD P15428 1/20 0.35
ALOX12 P18054 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21385367 0.91 HPRT1 (0.47) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL19844146 0.88 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL10021267 0.85 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12757681 0.85 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12225434 0.83 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12224657 0.78 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL29496057 0.76 CYP3A4 (0.53) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12031962 0.76 MEN1 (0.42) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL12224268 0.75 CCR1 (0.37) ALDH1A1SMN1; SMN2LMNAHTTMEN1
SCHEMBL20265562 0.74 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2LMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455866-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-06-04 US disclosed
US-8455866-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-06-04 US disclosed
US-20110240977-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-10-06 US disclosed
US-20110240977-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110240977-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME IDO1, LEF1, TPH1 ALDH1A1 1060/4885SMN1; SMN2 3472/4885LMNA 1356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.